The 8th Annual Bioassays and Bioanalytical Method Development event is taking place in 3 weeks – October 1-3 in Berkley - and all the leaders in the bioanalytical R&D industry will be there including Vice Presidents, Heads, Directors and Sr. Scientists from:
* Abbott Biotherapeutics * Alexion Pharmaceuticals * Algorithme Pharma * Ambrx * Amgen * Amylin Pharmaceuticals * ATCC * AVEO Pharmaceuticals * Bavarian Nordic GmbH * BioAgilytix Labs * Biogen Idec * BioMonitor A/S * Catalent Pharma Solutions * Charles River Laboratories * Cirion Clinical Trial Services * Crucell * Eli Lilly * EMD Millipore * ENS - Cachan * Epizyme * Eureka Therapeutics * Fresenius Kabi USA * Genentech * Genzyme * GlaxoSmithKline * GSK Biologicals * Healthpoint * Human Genome Sciences * Immunogen * Incyte * Inovio Biomedical * Jennerex * MedImmune * Merck & Company * Merck KGaA * Merz Pharmaceuticals GmbH * OncoMed Pharmaceuticals * Pfizer * Planet Biotechnology * Promega * Regeneron Pharmaceuticals * RMC Pharmaceutical Solutions * Stem CentRx * University of California * Vaxinnate * Visterra *
The 8th annual Bioassays and Bioanalytical Method Development Conference will take place October 1-3, 2012 in Berkley, California. As a reader of this blog, when you register to join us today and mention code XP1768BLOG, you’ll save 15% off the standard rate! If you have any questions, feel free to contact Jennifer Pereira.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment